The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Interactions · continued

Antibiotics and a course of something with delayed emptying posts 31–60

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

KP
k.pereiraTL2 Moderator30 Apr 2025#31

Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well.

10 likes 15mo
RV
r.venkatesanTL3Wiki editor2 May 2025#32
stopper_trace, post #2: Picking up the opening post: that is the part I would want checked first. Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion. Go to post

Worth separating two things that post #28 runs together.

Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management.

23 likes in reply to #2 15mo
PK
p.krastevTL2 Moderator3 May 2025#33

Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches.

0 likes 15mo
IS
isotonic_sheetTL3Regular4 May 2025#34

Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this.

3 likes 15mo
NK
ni.kravchenkoTL2 Moderator6 May 2025#35
r.venkatesan, post #32: Worth separating two things that post #28 runs together. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active… Go to post

post #34 answers the question as asked. The question underneath it is different.

Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.

6 likes in reply to #32 15mo
RJ
r.jhannsdttirTL3Regular7 May 2025#36
NLoughran, post #6: Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well. Go to post

On post #32 — agreed on the reasoning, with one qualification.

Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.

16 likes in reply to #6 15mo
RS
r.sobczakTL2 Moderator9 May 2025#37

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

0 likes 15mo
EA
e.almeidaTL2Member10 May 2025#38

Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction.

1 like 15mo
PN
p.novakTL2 Moderator11 May 2025#39

SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.

3 likes 15mo
I
IHollingworthTL2Member13 May 2025#40
MSaarinen, post #11: Picking up post #8: that is the part I would want checked first. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination. Go to post

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

11 likes in reply to #11 15mo
J
JFitzgibbonTL2Member14 May 2025#41

Worth separating two things that post #37 runs together.

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

7 likes 14mo
ND
n.dziedzicTL2 Moderator16 May 2025#42

Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration is to limit it.

1 like 14mo
AS
a.salcedoTL317 May 2025#43
NN
n.nakamuraTL2 Moderator18 May 2025#44
p.novak, post #39: SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern. Go to post

Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this.

24 likes in reply to #39 14mo
CD
cohort_driftTL3Regular20 May 2025 · edited#45

Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.

11 likes 14mo
SO
s.okonkwoTL2 Moderator21 May 2025#46

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

3 likes 14mo
SS
stopper_shiftTL1Member22 May 2025#47
OFalkenberg, post #10: Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable. Go to post

Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction.

0 likes in reply to #10 14mo
TV
to.vargaTL2 Moderator24 May 2025#48

Picking up post #45: that is the part I would want checked first.

Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close together. Separating them by a few hours is the conservative approach.

32 likes 14mo
FF
f.fonsecaTL2 Moderator25 May 2025#49

Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management.

1 like 14mo
FW
f.wojcikTL2 Moderator26 May 2025#50

Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well.

0 likes 14mo
LP
l.parkinsonTL2Member28 May 2025#51

Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination.

12 likes 14mo
NH
n.hartmannTL2 Moderator29 May 2025#52

I read post #50 twice before replying, because I had assumed the opposite.

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

26 likes 14mo
CP
citation_peakTL3Regular30 May 2025#53
z.nakamura, post #18: Worth separating two things that post #14 runs together. Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions… Go to post

post #52 is right about the mechanism and I think understates the practical bit.

SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.

0 likes in reply to #18 14mo
MN
ma.nascimentoTL2 Moderator31 May 2025#54

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

2 likes 14mo
N
NLoughranTL3Regular2 Jun 2025#55

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

18 likes 14mo
KK
k.karlsenTL2 Moderator3 Jun 2025#56
l.parkinson, post #51: Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination. Go to post

Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration is to limit it.

0 likes in reply to #51 14mo
VS
vial_slopeTL3Regular4 Jun 2025#57

post #56 answers the question as asked. The question underneath it is different.

Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.

0 likes 14mo
VM
v.malinowskiTL2 Moderator6 Jun 2025#58

On post #54 — agreed on the reasoning, with one qualification.

Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches.

4 likes 14mo
LA
l.aaltonenTL3Regular7 Jun 2025 · edited#59

Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close together. Separating them by a few hours is the conservative approach.

4 likes 14mo
SM
so.mbekiTL2 Moderator8 Jun 2025#60
b.brandt, post #14: Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction. Go to post

Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction.

13 likes in reply to #14 14mo